F757 in Delaware. Pick another state for the same tag.
Against expectation — 2025
Delaware cites F757 more often than its own record predicts
Versus expected share1.34×
1.34 times the share F757 takes of citations nationally.
Share of Delaware citations1.06%
Of every deficiency written in Delaware in 2025, this is the portion that was F757.
Delaware1.06%
National0.80%
Share of all citations that were F757.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Delaware surveyors wrote
F757 findings written in Delaware, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedMay 22, 2026
Based on record review and interview it was determined that for one (R1) out of five residents sampled for medication review, the facility failed to ensure that R1 received medication with adequate monitoring. Findings include:Review of R1's clinical record revealed: 2/27/26 - R1 was admitted to the facility. 3/7/26 - A care plan documented that R1 had high blood pressure with the following interventions: administer medications per physician orders; assess for signs and symptoms of high blood pressure; and monitor blood pressure as indicated. 4/7/26 - A physician's order documented Losartan Potassium 25 mg give one tablet by mouth one time a day for hypertension: hold is systolic blood pressure (SBP) is less than 120 mmHg. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction